Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir in Chronic Heart Failure
NCT05008679Unknown
- Sponsor
- Tongji Hospital
- Start
- Feb 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of oseltamivir in heart failure (HF) (2 arms), sponsored by Tongji Hospital. Primary endpoint: N-terminal pro-brain natriuretic peptide at 1 month. Status: unknown.
02
Drugs
oseltamivir
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05008679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05008679.